This finding supports our previous findings [48], where in a hormone receptor-positive BC cohort of 102 patients, both a lower ID and a higher CM indicator, reflecting the positive immunogradient of CD8+ T-cells toward the tumor within the IZ, were strongly associated with better overall survival. The gene discussed is CD8A; the disease is breast cancer.